Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Meeting Report of the 37th International Conference on Antiviral Research in Gold Coast, Australia, May 20-24, 2024, organized by the International Society for Antiviral Research.

Autor: Welch SR; Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: swelch1@cdc.gov., Bilello JP; Gilead Sciences, Inc., Foster City, CA, USA., Carter K; Evotec US, Princeton, NJ, USA., Delang L; Virus-Host Interactions & Therapeutic Approaches Research Group, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium., Dirr L; Institute for Biomedicine and Glycomics, Griffith University, Southport, QLD, Australia., Durantel D; Centre International de Recherche en Infectiologie (CIRI), Inserm_U1111, CNRS_UMR5308, Université Claude Bernard Lyon 1, F-69007, Lyon, France., Feng JY; San Francisco, California, USA., Gowen BB; Institute for Antiviral Research and Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, UT, USA., Herrero LJ; Institute for Biomedicine and Glycomics, Griffith University, Southport, QLD, Australia., Janeba Z; Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, 160 00 Prague, Czech Republic., Kleymann G; Innovative Molecules GmbH, Lipowsky Str. 10, 81373, Munich, Bavaria, Germany., Lee AA; PostEra Inc, 1 Broadway, Cambridge MA, USA., Meier C; Organic Chemistry, Department of Chemistry, Faculty of Sciences, University of Hamburg, Martin-Luther-King-Platz 6, Hamburg, Germany., Moffat J; Department of Microbiology & Immunology, SUNY Upstate Medical University, Syracuse, NY USA., Schang LM; Baker Institute and Department of Microbiology and Immunology, Cornell University, Ithaca, NY, USA., Schiffer JT; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Diseases Division, Seattle, Washington, USA; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA., Seley-Radtke KL; Department of Chemistry & Biochemistry, University of Maryland, Baltimore County, Baltimore, MD, USA., Sheahan TP; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC, USA; Rapidly Emerging Antiviral Drug Development Initiative, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Spengler JR; Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: jspengler@cdc.gov.

Publikováno v: Antiviral research [Antiviral Res] 2024 Nov 12, pp. 106037. Date of Electronic Publication: 2024 Nov 12.